Osborne Clarke advises the investors of the $50M Series B financing round of BioClin Therapeutics
International legal practice Osborne Clarke represented new investors INKEF Capital and Sectoral Asset Management as well as existing investors Sofinnova...
Published on
16/05/2018
Read time
1m